Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Otsuka Pharmaceutical to Acquire Neurovance, Expand CNS Sector Engagement

Filed Under: Industry, Pharma Tagged With: , , , , , ,

Otsuka Pharmaceutical Co. Ltd. on March 3 announced that it will acquire U.S.-based bioventure Neurovance Inc., which is developing a treatment…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Asahi Kasei Medical to Enter Pharmaceutical CDMO Business
Asahi Kasei Medical to Enter Pharmaceutical CDMO Business
Japan’s Leading Drug Manufacturers Grow Sales Revenue on Back of Mainstay Products
Japan’s Leading Drug Manufacturers Grow Sales Revenue on…
AGC Looks to Advance Into Gene and Cell Therapy Business With Tender Offer for MolMed
AGC Looks to Advance Into Gene and Cell Therapy Business…
Overview of Major M&A Projects Under Japanese Chemical Companies in 2020
Overview of Major M&A Projects Under Japanese Chemical…
Ube Industries to Acquire Premium Composite Technology North America
Ube Industries to Acquire Premium Composite Technology North…
Shin-Etsu Chemical Prepares Launch of Spray Drying Service for Easy-to-Dissolve Drug Substances
Shin-Etsu Chemical Prepares Launch of Spray Drying Service…